Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Drugs Payment Scheme

Dáil Éireann Debate, Tuesday - 2 May 2017

Tuesday, 2 May 2017

Ceisteanna (1061)

Eamon Scanlon

Ceist:

1061. Deputy Eamon Scanlon asked the Minister for Health the position regarding making the immunotherapy drug nivolumab available to cancer patients on the reimbursement scheme; the costs associated with treating each person on an annual basis; and if he will make a statement on the matter. [20390/17]

Amharc ar fhreagra

Freagraí scríofa

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.

Barr
Roinn